Real-time detection of influenza a, influenza B, and respiratory syncytial virus a and B in respiratory specimens by use of nanoparticle probes.
Seasonal epidemics of influenza and respiratory syncytial virus are responsible for significant morbidity and mortality worldwide. Infrequently, novel or reemergent strains of influenza A virus have caused rapid, severe global pandemics resulting in millions of fatalities. The ability to efficiently and accurately detect and differentiate respiratory viruses is paramount for effective treatment, infection control, and epidemiological surveillance. We evaluated the ability of two FDA-cleared nucleic acid-based tests, the semiautomated respiratory virus nucleic acid test (VRNAT) and the fully automated respiratory virus nucleic acid test SP (RVNAT(SP)) (Nanosphere Inc., Northbrook, IL) to detect influenza A virus, influenza B virus, and respiratory syncytial virus A and B (RSV A/B) from clinical nasopharyngeal swab specimens. Detection of viral RNA in both tests is based on nucleic acid amplification followed by hybridization to capture probes immobilized on a glass slide. A novel technology utilizing gold nanoparticle-conjugated probes is utilized to detect the presence of captured target DNA. This microarray-based approach to detection has proven to be more sensitive than the traditional culture/direct fluorescent-antibody assay (DFA) method for detecting RSV and influenza viruses in clinical specimens, including the novel 2009 H1N1 strain. Specifically, we report 98.0% sensitivity and 96.5% specificity for the VRNAT compared to culture/DFA. Further, the VRNAT detected virus in an additional 58% of specimens that were culture negative. These data were confirmed using bidirectional sequencing. Evaluation of the fully automated RVNAT(SP), which is built on the same detection technology as the VRNAT but contains an updated processor enabling complete automation, revealed the two tests to be functionally equivalent. Thus, the RVNAT(SP) is a fully automated sample-to-result test capable of reliable detection of select respiratory viruses directly from clinical specimens in 3.5 h.
Jannetto
Paul J
PJ
Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Buchan
Blake W
BW
Vaughan
Kimberly A
KA
Ledford
Joellen S
JS
Anderson
Dennis K
DK
Henley
Donald C
DC
Quigley
Neil B
NB
Ledeboer
Nathan A
NA
D006801:Humans; D009980:Influenza A virus / Q000302:isolation & purification*; D009981:Influenza B virus / Q000302:isolation & purification*; D046228:Microarray Analysis / Q000379:methods; D053758:Nanoparticles; D009305:Nasopharynx / Q000821:virology; D015345:Oligonucleotide Probes; D012367:RNA, Viral / Q000235:genetics / Q000302:isolation & purification; D012136:Respiratory Syncytial Viruses / Q000302:isolation & purification*; D012141:Respiratory Tract Infections / Q000821:virology*; D012680:Sensitivity and Specificity; D014773:Virology / Q000379:methods; D014777:Virus Diseases / Q000175:diagnosis* / Q000821:virology
D015345:Oligonucleotide Probes; D012367:RNA, Viral
J Clin Virol. 2009 Jul;45(3):191-5
19540158
Science. 1997 Aug 22;277(5329):1078-81
9262471
Emerg Infect Dis. 2010 Jan;16(1):8-13
20031036
J Pediatr. 2003 Nov;143(5 Suppl):S118-26
14615710
J Clin Microbiol. 2007 Nov;45(11):3807-10
17855577
Anal Chem. 2006 Nov 15;78(22):7610-5
17105150
J Clin Microbiol. 2001 May;39(5):1696-701
11325976
Expert Rev Vaccines. 2008 Oct;7(8):1239-55
18844597
J Mol Diagn. 2010 Jan;12(1):74-81
19959800
J Clin Microbiol. 2003 Jul;41(7):3407-9
12843105
Clin Infect Dis. 2009 Oct 1;49(7):1090-3
19725784
J Clin Microbiol. 2002 Jun;40(6):2051-6
12037063
Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):280-3
11399021
Clin Microbiol Rev. 2010 Jan;23(1):74-98
20065326
Clin Microbiol Rev. 2000 Jul;13(3):371-84
10885982
J Clin Virol. 2008 Jul;42(3):249-53
18378492
J Clin Microbiol. 2003 Sep;41(9):4298-303
12958260
J Clin Microbiol. 2006 Aug;44(8):2863-71
16891504
Virus Genes. 2009 Dec;39(3):279-92
19809872
J Clin Microbiol. 2008 Feb;46(2):789-91
18057126
Emerg Infect Dis. 2006 Jun;12(6):881-6
16707041
Biosens Bioelectron. 2004 Mar 15;19(8):875-83
15128107
Diagn Microbiol Infect Dis. 2008 Jun;61(2):192-7
18296004
J Virol Methods. 2010 May;165(2):254-60
20153377
J Clin Virol. 2009 Jul;45(3):200-2
19515609
J Clin Microbiol. 2004 Apr;42(4):1564-9
15071005
J Clin Microbiol. 2007 Sep;45(9):2965-70
17596360
J Clin Microbiol. 2009 Mar;47(3):527-32
19129410
J Clin Microbiol. 2007 Apr;45(4):1234-7
17301287
Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1861-70
11779385
MMWR Morb Mortal Wkly Rep. 2009 Aug 7;58(30):826-9
19661856
Clin Chim Acta. 2006 Jan;363(1-2):120-6
16214124
Clin Microbiol Rev. 2008 Oct;21(4):716-47
18854489
Diagn Microbiol Infect Dis. 2007 Aug;58(4):413-8
17509800